From The Next Web · Cristian Dina · · 1m
Science raises $400m for brain implant restoring sight
Max Hodak's brain-computer interface company has secured $3.5bn valuation funding to expand its vision-restoring device across Europe and into the US.
In brief
Max Hodak's brain-computer interface company has secured $3.5bn valuation funding to expand its vision-restoring device across Europe and into the US. Science Corporation raised four hundred million dollars in Series D funding to expand PRIMA, a brain implant that restores form vision for people with macular…
Science raises $400m for vision implant

Science Corporation, founded by former Neuralink president Max Hodak, has raised four hundred million dollars in Series D funding. The round values the brain-computer interface company at three point five billion dollars.
PRIMA restores ability to read and see letters
Science's first product, PRIMA, is a wearable and implantable chip for people with age-related macular degeneration.
Funding expands PRIMA to US and Europe
PRIMA launched in Europe and is available in Germany. Science will use the funding to expand across more of Europe and prepare a US launch through the FDA's Humanitarian Device Exemption for rare conditions.
At a glance
Science Corporation raised four hundred million dollars in Series D funding to expand PRIMA, a brain implant that restores form vision for people with macular degeneration.
Read the TL;DR — this story on one card.




